scispace - formally typeset
J

Jessika C. Zevenhoven-Dobbe

Researcher at Leiden University Medical Center

Publications -  39
Citations -  5491

Jessika C. Zevenhoven-Dobbe is an academic researcher from Leiden University Medical Center. The author has contributed to research in topics: Coronavirus & RNA. The author has an hindex of 23, co-authored 39 publications receiving 4280 citations.

Papers
More filters
Journal ArticleDOI

SARS-Coronavirus Replication Is Supported by a Reticulovesicular Network of Modified Endoplasmic Reticulum

TL;DR: The ultrastructural description of this “replication network” will aid to further dissect the early stages of the coronavirus life cycle and its virus-host interactions.
Journal ArticleDOI

Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture

TL;DR: Four compounds are identified inhibiting MERS-CoV replication in the low-micromolar range (50% effective concentrations [EC50s], 3 to 8 μM) and may offer a starting point for treatment of patients infected with zoonotic coronavirus infections.
Journal ArticleDOI

One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities

TL;DR: This study reveals that the SARS-coronavirus RNA polymerase (nsp12) needs to associate with nsp7 and nsp8 to activate its capability to replicate long RNA and defines the core of an RNA-synthesizing machinery that is unique in the RNA virus world and includes several key targets for antiviral drug development.
Journal ArticleDOI

Ultrastructure and Origin of Membrane Vesicles Associated with the Severe Acute Respiratory Syndrome Coronavirus Replication Complex

TL;DR: In this article, a panel of replicase-specific antisera was used to analyze the earlier stages of severe acute respiratory syndrome coronavirus (SARS-CoV) infection in Vero E6 cells.
Journal ArticleDOI

SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.

TL;DR: The sensitivity of the two viruses to three established inhibitors of coronavirus replication is very similar, but that SARS-CoV-2 infection was substantially more sensitive to pre-treatment of cells with pegylated interferon alpha.